Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Evolve Telemed vs Queen RX

Evolve Telemed
Graded #378

Lower grade

vs+7.899999999999999
Queen RX
Graded #212

Higher grade

The verdict

Queen RX takes it — 66/100 to 58.1/100.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +31
45
76
Dose & formulationQueen RX +4
53
57
Clinical oversightEvolve Telemed +14
83
69
Labs & monitoringQueen RX +1
52
53
FulfillmentQueen RX +13
62
75
Contract termsQueen RX +6
55
61
Evolve Telemed · left barQueen RX · right bar

The numbers

MetricEvolve TelemedQueen RX
WeighScore58.1/10066/100
GradeCC
Scorecard rank#378#212
SemaglutideNot disclosed$100/mo (quarterly plan, compounded)
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published45 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Evolve Telemed

Graded #378 · C

Strengths

  • Established hormone- and peptide-optimization brand with board-certified specialists and a physician-plus-care-specialist support model
  • Compounded GLP-1 (semaglutide) weight care offered alongside TRT, menopause/BHRT, thyroid and sexual-wellness programs in one practice
  • Coordinated couples care plans plus dedicated men's and women's tracks
  • Free consultation to start, with published press, blog and FAQ resources

Where it loses points

  • No GLP-1 pricing published — cost is only revealed after a consultation, so you can't compare value upfront
  • Doesn't list the states it serves or name its compounding pharmacies
  • Weight loss is one of many verticals, not a dedicated GLP-1-first program
  • Tirzepatide availability isn't confirmed on the site; only compounded semaglutide is referenced
  • Not shown on our price-ranked /best lists because no pricing is disclosed
Queen RX

Graded #212 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard